{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:11:26Z","timestamp":1789755086653,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013806","name":"Shenyang Pharmaceutical University","doi-asserted-by":"publisher","award":["YQ202203"],"award-info":[{"award-number":["YQ202203"]}],"id":[{"id":"10.13039\/501100013806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A2026092"],"award-info":[{"award-number":["A2026092"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Basic Research Program","doi-asserted-by":"publisher","award":["A2503056"],"award-info":[{"award-number":["A2503056"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104061"],"award-info":[{"award-number":["82104061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404782"],"award-info":[{"award-number":["82404782"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cellsig.2026.112875","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:04:17Z","timestamp":1788537857000},"page":"112875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cycloechinulin inhibits breast cancer progression via the SGOL2\/METTL3\/ICAM2 signaling axis and suppresses the growth of breast cancer patient-derived organoids"],"prefix":"10.1016","volume":"149","author":[{"given":"Shuxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boning","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112875_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2026.112875_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112875_bb0015","first-page":"265","article-title":"Diagnosis, prognosis, and treatment of triple-negative breast cancer: a review","volume":"17","author":"Jie","year":"2025","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.cellsig.2026.112875_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112875_bb0025","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1158\/0008-5472.CAN-20-1792","article-title":"Association of pathologic complete response with long-term survival outcomes in triple-negative breast cancer: a meta-analysis","volume":"80","author":"Huang","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112875_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01509-2","article-title":"The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors","volume":"17","author":"Wei","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112875_bb0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa1814213","article-title":"Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer","volume":"380","author":"Bardia","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2026.112875_bb0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2026.112875_bb0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2026.112875_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112875_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.cellsig.2026.112875_bb0060","first-page":"232","article-title":"A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology","volume":"3","author":"Guillen","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.cellsig.2026.112875_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05824-1","article-title":"Advancing cancer research through organoid technology","volume":"22","author":"Zeng","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112875_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156155","article-title":"Artemisitene induces apoptosis of breast cancer cells by targeting FDFT1 and inhibits the growth of breast cancer patient-derived organoids","volume":"135","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cellsig.2026.112875_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154752","article-title":"Oxypalmatine regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K\/AKT signaling and its efficacy against breast cancer organoids","volume":"114","author":"Lin","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cellsig.2026.112875_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116871","article-title":"Liensinine diperchlorate and artemisitene synergistically attenuate breast cancer progression through suppressing PI3K-AKT signaling and their efficiency in breast cancer patient-derived organoids","volume":"176","author":"Lin","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112875_bb0085","doi-asserted-by":"crossref","first-page":"11103","DOI":"10.1002\/jcp.27761","article-title":"Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines","volume":"234","author":"Kundur","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellsig.2026.112875_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.993775","article-title":"Berberine as a potential agent for breast cancer therapy","volume":"12","author":"Zhong","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112875_bb0095","article-title":"Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: an integrated study of bioinformatics analysis","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cellsig.2026.112875_bb0100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s13277-014-2754-7","article-title":"Berberine-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species generation and mitochondrial-related apoptotic pathway","volume":"36","author":"Xie","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cellsig.2026.112875_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24162899","article-title":"The inhibitory effect of (\u2212)-epigallocatechin-3-gallate on breast cancer progression via reducing SCUBE2 methylation and DNMT activity","volume":"24","author":"Sheng","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.cellsig.2026.112875_bb0110","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/ptr.6081","article-title":"Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation","volume":"32","author":"Li","year":"2018","journal-title":"Phytother. Res."},{"key":"10.1016\/j.cellsig.2026.112875_bb0115","article-title":"Exploration of the use of natural compounds in combination with chemotherapy drugs for tumor treatment","volume":"28","author":"Wu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.cellsig.2026.112875_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155600","article-title":"Natural products and derivatives for breast cancer treatment: from drug discovery to molecular mechanism","volume":"129","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cellsig.2026.112875_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1039\/D5NP00080G","article-title":"Marine natural products","volume":"43","author":"Carroll","year":"2026","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.cellsig.2026.112875_bb0130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1248\/cpb.58.717","article-title":"Novoamauromine and ent-cycloechinulin: two new diketopiperazine derivatives from Aspergillus novofumigatus","volume":"58","author":"Ishikawa","year":"2010","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.cellsig.2026.112875_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","article-title":"Roles of METTL3 in cancer: mechanisms and therapeutic targeting","volume":"13","author":"Zeng","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112875_bb0140","article-title":"ICAM2 promotes endocrine resistance via dynein-mediated OXPHOS activation in ER-positive breast cancer","author":"Chen","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112875_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1148","article-title":"Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3-mediated N6-methyladenosine modification of ICAM2 mRNA in fibroblast-like synoviocytes","volume":"12","author":"Chen","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112875_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01278-4","article-title":"Tumor organoids: applications in cancer modeling and potentials in precision medicine","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112875_bb0155","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1101\/gad.475308","article-title":"SGOL2\/METTL3\/ICAM2\u20132 is essential for the completion of meiosis but not for mitotic cell division in mice","volume":"22","author":"Llano","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.cellsig.2026.112875_bb0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40364-022-00422-z","article-title":"SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma","volume":"10","author":"Hu","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cellsig.2026.112875_bb0165","doi-asserted-by":"crossref","first-page":"10050","DOI":"10.18632\/aging.204443","article-title":"SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination","volume":"14","author":"Lv","year":"2022","journal-title":"Aging (Albany NY)"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:42:28Z","timestamp":1789753348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826005346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":33,"alternative-id":["S0898656826005346"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112875","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cycloechinulin inhibits breast cancer progression via the SGOL2\/METTL3\/ICAM2 signaling axis and suppresses the growth of breast cancer patient-derived organoids","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112875"}}